Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Receivables - Net: 2020-2024

Historic Receivables - Net for Caribou Biosciences (CRBU) over the last 5 years, with Dec 2024 value amounting to $265,000.

  • Caribou Biosciences' Receivables - Net rose 31.52% to $242,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $242,000, marking a year-over-year increase of 31.52%. This contributed to the annual value of $265,000 for FY2024, which is 79.05% up from last year.
  • Latest data reveals that Caribou Biosciences reported Receivables - Net of $265,000 as of FY2024, which was up 79.05% from $148,000 recorded in FY2023.
  • Caribou Biosciences' 5-year Receivables - Net high stood at $1.2 million for FY2021, and its period low was $148,000 during FY2023.
  • For the 3-year period, Caribou Biosciences' Receivables - Net averaged around $205,000, with its median value being $202,000 (2022).
  • Per our database at Business Quant, Caribou Biosciences' Receivables - Net spiked by 668.67% in 2021 and then tumbled by 82.48% in 2022.
  • Over the past 5 years, Caribou Biosciences' Receivables - Net (Yearly) stood at $150,000 in 2020, then skyrocketed by 668.67% to $1.2 million in 2021, then crashed by 82.48% to $202,000 in 2022, then declined by 26.73% to $148,000 in 2023, then soared by 79.05% to $265,000 in 2024.